CAS: 24623-20-9; 6-Methyl-1-Indanone

上下游产品

CAS号201230-82-2 carbon monoxide | CAS号4186-14-5 三甲基(对甲苯乙炔)硅烷 | CAS号828267-46-5 2-bromo-1-ethen... | CAS号103040-39-7 Benzenepropanoy... | CAS号1505-50-6 3-(4-甲苯)丙酸 | CAS号58183-40-7 Benzenepropanoy... | CAS号104-87-0 对甲基苯甲醛 | CAS号1866-39-3 对甲基肉桂酸 | CAS号3351-31-3 3-甲基屈 | CAS号200425-63-4 6-甲基-2,3-二氢-1H-茚-1-醇 | CAS号24633-70-3 Benzoyl chlorid... | CAS号361389-84-6 (9ci)-2,3-二氢-6-... | CAS号17059-48-2 1H-INDENE,2,3-D... | CAS号7480-80-0 5-methyl-1h-indene | CAS号874-35-1 5-甲基-2,3-二氢-1H-茚 | CAS号881-21-0 1-Indanol, 2-is... | CAS号52310-59-5 3,5-dimethyl-1H...

4-Methylcinnamic Acid置于palladium On Activated Charcoal 三氯化铝,氯化亚砜,氢气体系中,用 二硫化碳,乙醇 用作溶剂,5.0 °C,101.33 Kpa 条件下,反应 5.67H,反应生成6-甲基-1-茚酮
参考文献:Collins,Michael J.; Gready,Jill E.; Sternhell,Sever,Australian Journal Of Chemistry,1990,Vol. 43,P. 1547-1557
标题:Collins,Michael J.; Gready,Jill E.; Sternhell,Sever,Australian Journal Of Chemistry,1990,Vol. 43,P. 1547-1557

专利信息

专利号:WO-2023122754-A1
优先权日:2021-12-23
标 题 :Processes and intermediates for preparing gb13, gb22 and himgaline
发明人：LANDWEHR ELEANOR; SHENVI RYAN; BAKER MEGHAN; OGUMA TAKUYA
权利人:SCRIPPS RESEARCH INST
摘要:Provided herein are processes for the streamlined synthesis of Galbulimima alkaloids, such as himbadine, isolated from Galbulimima belgraveana and G. baccatta, trees endemic to the rainforests of Northern Australia and Papua New Guinea, as well as analogs thereof, such as GB13, GB16, GB22, and himgaline, and further including intermediates useful in the synthesis of these and related compounds.

专利号:US-6316437-B1
优先权日:1999-09-30
标题:Spirohydantoin compounds and uses thereof
发明人：HOFFMAN JACOB M
权利人:MERCK & CO INC
摘要:Spirohydantoin compounds and their pharmaceutically acceptable salts are disclosed. The synthesis of these compounds and their use as alpha 1a adrenergic receptor antagonists is also described. One application of these compounds is in the treatment of benign prostatic hyperplasia. These compounds are typically selective in their ability to relax smooth muscle tissue enriched in the alpha 1a receptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia can be achieved.

专利号:US-2023002426-A1
优先权日:2019-11-15
标题 :Chiral synthesis of a tertiary alcohol

专利号:US-2013267712-A1
优先权日:2012-04-02
标题 :Aromatic ketone synthesis with amide reagents and related reactions
发明人：KLUMPP DOUGLAS A; RAJA ERUM K
权利人:KLUMPP DOUGLAS A; RAJA ERUM K; UNIV NORTHERN ILLINOIS
摘要:A method of preparing an aryl carbonyl or aryl thiocarbonyl compound, comprises reacting an N-(nitroaryl)-amide or N-(nitroaryl)-thioamide with an aromatic ring, with a superacid catalyst, to produce the aryl carbonyl or aryl thiocarbonyl compound. The superacid is present in an amount of at most 8 equivalents in proportion to the N-(nitroaryl)-amide or N-(nitroaryl)-thioamide. A method of preparing aryl amide or aryl thioamide, comprises reacting an N-(nitroaryl)-carbamide or N-(nitroaryl)-thiocarbamide with an aromatic ring, with a superacid catalyst, to produce the aryl amide or aryl thioamide.

专利号:WO-2021097139-A1
优先权日:2019-11-15
标 题 :Chiral synthesis of a tertiary alcohol

专利号:WO-9845272-A1
优先权日:1997-04-07
标题:Topoisomerase inhibitors
发明人：DEADY LESLIE WILLIAM; DENNY WILLIAM ALEXANDER; KAYE ANTHONY JAMES
权利人:UNIV LATROBE; DEADY LESLIE WILLIAM; DENNY WILLIAM ALEXANDER; KAYE ANTHONY JAMES
摘要:The invention provides a novel series of tetracyclic quinoline and quinoxaline carboxamides, bis compounds in which two of the tetracyclic compounds are joined by a linker, and pharmaceutically-acceptable salts and N-oxides thereof, which have the ability to inhibit topoisomerase activity. The compounds are active in vitro and in vivo against tumour cells. Methods of synthesis and pharmaceutical compositions are also claimed.